Quick Answer
Forte Biosciences, Inc. reported Net Income Loss of -$69.38 million for the year ending 2025.
- Forte Biosciences, Inc. showed a decrease of -95.5% in Net Income Loss from 2024 to 2025.
- This data is from Forte Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), Forte Biosciences, Inc.'s Net Income Loss has declined by 200.9%.
- Historical annual values: Fiscal year 2025: -$69.38 million | Fiscal year 2024: -$35.48 million | Fiscal year 2023: -$31.48 million | Fiscal year 2022: -$13.88 million | Fiscal year 2021: -$21.71 million | Fiscal year 2020: -$46.49 million | Fiscal year 2019: -$4.07 million | Fiscal year 2018: -$48.96 million | Fiscal year 2017: -$38.93 million | Fiscal year 2016: -$33.48 million | Fiscal year 2015: -$23.06 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: